Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Fluid handling structure, a lithographic apparatus and a device manufacturing method
System and method for data reconfiguration in an optical communication network
Train car for proppant containers
Presenting a link to a user
Support for a portable electronic device
Binder for secondary battery providing excellent adhesion strength and cycle property
Tropoelastin derivatives
  Randomly Featured Patents
Parenteral solution delivery control system
Multifunctional, granulated pellet aid and process
Device for exchanging a tape drive mode
Device for placement in a bathtub or similar structure as an entering and exiting aid
Air over hydraulics actuator system
Methods and systems for alkyl ester production
Pressure printing apparatus
Filter head
Control system for disc playing device
Access terminal conditionally opening a data session